The development of our models also included variables related to cardiovascular and diabetes risk that are considered in these tools; however, our main goal was to create a more robust model that incorporates new anthropometric indices, metabolic profiles, and the role of adiponectin as an indicator of its impact on the development of metabolic syndrome. This evidence concerns the gene ADIPOQ and diabetes mellitus.